Original article| Volume 34, ISSUE 10, P844-851, November 2012

Download started.


Antiamnesic activity of Syzygium cumini against scopolamine induced spatial memory impairments in rats


      We evaluated the Antiamnesic effects of methanolic extract of Syzygium cumini (MESC) on spatial memory impairments induced by scopolamine (1 mg/kg, i.p.), a muscarinic antagonist, using the Radial arm maze, Morris water maze, learned helpless ness tests. Effect of MESC was evaluated and compared to standard drug, piracetam (200 mg/kg, i.p.). The MESC significantly (p < 0.05) improved the impairment of short term or working memory induced by scopolamine in the Radial arm maze test, and significantly (p < 0.05) reversed cognitive impairments in rats as measured by the learned helplessness test. In addition, MESC decreased escape latencies in the Morris water maze test. The activity of acetylcholinesterase in the brain was inhibited significantly (p < 0.05) by treatment with MESC to a level similar to that observed in rats treated with piracetam. Moreover treatment with MESC (200 and 400 mg/kg, p.o.) to scopolamine induced rats significantly (p < 0.05) decreased TBARS levels which was accompanied by an increase in the activities of SOD and Catalase. MESC has dose dependent effect and 400 mg/kg dose shown more prominent results when compared to 200 mg/kg dose of MESC. These results indicate that MESC may exert anti-amnesic activity via inhibition of acetylcholinesterase and antioxidant mechanisms in the brain.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dunning J.
        • Matthew J.D.
        Molecular mechanisms of learning and memory.
        Expert Rev Mol Med. 2003; 5: 1-11
        • Selkoe D.J.
        The molecular pathology of Alzheimer’s disease.
        Neuron. 1991; 6: 487-498
        • Blokland A.
        Acetylcholine: a neurotransmitter for learning and memory?.
        Brain Res Rev. 1996; 21: 285-300
        • Giacobini E.
        The cholinergic system in Alzheimer disease.
        Prog Brain Res. 1990; 84: 321-332
        • Ebert U.
        • Kirch W.
        Scopolamine model of dementia: electroencephalogram findings and cognitive performance.
        Eur J Clin Invest. 1998; 28: 944-949
        • Ovsepian S.V.
        • Anwyl R.
        • Rowan M.J.
        Endogenous acetylcholine lowers the threshold for long-term potentiation induction in the CA1 area through muscarinic receptor activation: in vivo study.
        Eur J Neurosci. 2004; 20: 1267-1275
        • Beatty W.W.
        • Butters N.
        • Janowsky D.S.
        Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.
        Behav Neural Biol. 1986; 45: 196-211
        • Bejar C.
        • Wang R.
        • Weinstock M.
        Effect of rivastigmine on scopolamine-induced memory impairment in rats.
        Eur J Pharmacol. 1999; 383: 231-240
        • Wesnes K.A.
        • Simpson P.M.
        • White L.
        • Pinker S.
        • Jertz G.
        • Murphy M.
        • et al.
        Cholinesterase inhibition in the scopolamine model of dementia.
        Ann NY Acad Sci. 1991; 640: 268-271
        • Kumar A.
        • Ilavarasan R.
        • Jayachandran T.
        • Decaraman M.
        • Aravindha P.
        Phytochemical investigation on a tropical plant, Syzygium cumini from Kattupalayam, Erode district, Tamilnadu, South India.
        Pak J Nut. 2009; 8: 83-85
        • Rekha Namasivayam
        • Balaji Ramachandran
        • Deecaraman Munuswamy
        Effect of aqueous extract of Syzygium cumini pulp on antioxidant defense system in streptozotocin induced diabetic rats.
        Iran J Pharmacol & Ther. 2008; 7: 137-145
        • Modi D.C.
        • Patel J.K.
        • Shah B.N.
        • Nayak B.S.
        Antiinflammatory activity of seeds of Syzygium cumini linn..
        J Pharm Educ. 2010; 1: 68-70
        • Chopra R.N.
        • Chopra I.C.
        • Handa K.L.
        Indigenous drugs of India.
        2nd ed. Dhar and Sons, Calcutta1958 (p. 686–9)
        • Bhuiyan M.A.
        • Mia M.Y.
        • Rashid M.A.
        Antibacterial principles of the seed of Eugenia jambolana.
        Banga J Bot. 1996; 25: 239-241
        • Kusumoto I.T.
        • Nakabayashi T.
        • Kida H.
        Screening of various plant extracts used in ayurvedic medicine for inhibitory effects on human immunodeficiencie virus type I (HIV-I) protease.
        Phytother Res. 1995; 9: 180-184
      1. Indira G, Mohan RJ. National Institute of Nutrition Indian council of Medical Research, Hyderabad 1993;34–7.

        • Reddy D.S.
        Assessment of Nootropic and amnesic activity of centrally acting drugs.
        Indian J Pharmacol. 1997; 29: 208-221
        • Smith C.P.S.
        • Hunter A.J.
        • Bennett G.W.
        Effects of (R)-ox-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze.
        Psychopharmacology. 1994; 114: 651-656
        • Sherman A.D.
        • Petty F.
        Additivity of neurochemical changes in learned helplessness and imipramine.
        Behav Neuro Biol. 1982; 35: 344-353
        • Ohkawa H.
        • Ohishi N.
        • Yagi K.
        Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction.
        Ann Biochem. 1979; 95: 351-358
        • Arutla S.
        • Arra G.S.
        • Prabhakar C.M.
        • Krishna D.R.
        Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on super oxide dismutase activity.
        Arzneim Forsch J Drug Res. 1998; 48: 1024
        • Beer R.F.
        • Seizer T.W.
        A spectrophotometric method for measuring breakdown of hydrogen peroxide by catalase.
        J Biol Chem. 1951; 115: 130-140
        • Lowry O.H.
        Colorimetric assays: Lowry method for Protein measurement with Folin-Phenol reagent.
        J Biol Chem. 1951; 193: 265-275
        • Ellman G.L.
        Tissue sulfhydryl groups.
        Arch Biochem Biophys. 1959; 82: 70-77
        • Vasudevan M.
        • Parle M.
        Antiamnesic potential of Murraya koenigii leaves.
        Phytother Res. 2009; 23: 308-316
        • Everitt B.J.
        • Robbins T.W.
        Central cholinergic systems and cognition.
        Annu Rev Psychol. 1997; 48: 649-684
        • Ballard C.G.
        • Greig N.H.
        • Guillozet-Bongaarts A.L.
        Cholinesterases: roles in the brain during health and disease.
        Curr Alzheimer Res. 2005; 2: 307-318
        • Achliya G.
        • Barhate U.
        • Wadokar S.
        • Dorle A.
        Effect of brahmi ghrita, a polyherbal formulation on learning and memory paradigms in experimental animals.
        Indian J Pharmacol. 2004; 3: 159-162
        • Morris R.G.
        Development of a water maze procedure for studying spatial learning in the rat.
        J Neurosci Methods. 1984; 11: 47-60
        • Barnes C.A.
        • Danysz W.
        • Parsons C.G.
        Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake, freely moving rats.
        Eur J Neurosci. 1996; 8: 565-571
        • Marcus D.L.
        • Thomas C.
        • Rodriquez C.
        • Simberkoff K.
        • Tsai J.S.
        • Strafaci J.A.
        • et al.
        Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer’s disease.
        Exp Neurol. 1998; 150: 40-44
        • El-Sherbiny D.A.
        • Khalifa A.E.
        • Attia A.S.
        • Eldenshary Eel D.
        Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine.
        Pharmacol Biochem Behav. 2003; 76: 525-533
        • Jimenez-Jimenez F.J.
        • Alonso-Navarro H.
        • Avuso-Peralta L.
        • Jabbour-Wadih T.
        Oxidative stress and Alzheimer’s disease.
        Rev Neurol. 2006; 42: 419-427
        • Yu S.P.
        • Canzoniero L.M.
        • Choi D.W.
        Ion homeostasis and apoptosis.
        Curr Opin Cell Biol. 2001; 13: 405-411
        • Schroeter H.
        • Williams R.J.
        • Matin R.
        • Iversen L.
        • Rice-Evans C.A.
        Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized lowdensity lipoprotein.
        Free Radic Biol Med. 2000; 29: 1222-1233
        • Schulz J.B.
        • Linderau J.
        • Seyfried J.
        • Dichgans J.
        Glutathione, oxidative stress and neurodegeneration.
        Eur J Biochem. 2000; 267: 4904-4911